R&D Breaking into the global pharmaceutical market In 2022, pharma is truly a global industry, and innovation can come from anywhere.
News Digital health accelerator Pulse launches in Boston Selected start-ups will receive part of a $250,000 pot.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
